Just – Evotec Biologics to Collaborate With Ology Bioservices on Antibodies Against Coronavirus

Evotec SE, a drug discovery alliance and development partnership company focused on innovative product approaches with leading pharmaceutical and biotechnology companies, announced that its Seattle-based subsidiary Just – Evotec Biologics, Inc. has entered into a partnership with UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), for the evaluation and analytical characterization of antibodies against SARS-CoV-2. This work falls under a contract awarded to Ology Bio by the Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense Enabling Biotechnologies to develop and manufacture monoclonal antibodies for treatment and prevention of infections with SARS-CoV-2.

This work is supported by the Office of the Assistant Secretary of Defense for Health Affairs with funding from the Defense Health Agency.

Learn more about Just – Evotec Biologics to Collaborate With Ology Bioservices on Antibodies Against Coronavirus.